68 FR 59 pg. 14967 - Notice of Intent To Grant Exclusive Patent License; American BioHealth Group, LLC
Type: NOTICEVolume: 68Number: 59Page: 14967
FR document: [FR Doc. 03-7351 Filed 3-26-03; 8:45 am]
Agency: Defense Department
Sub Agency: Department of the Navy
Official PDF Version: PDF Version
DEPARTMENT OF DEFENSE
Department of the Navy
Notice of Intent To Grant Exclusive Patent License; American BioHealth Group, LLC
AGENCY:
Department of the Navy, DOD
ACTION:
Notice.
SUMMARY:
The Department of the Navy hereby gives notice of its intent to grant to American BioHealth Group, LLC, a revocable, nonassignable, exclusive license in the United States to practice, with right to sublicense, the Government-owned invention described in U.S. Patent Application Serial No. 09/766, 625, entitled "Prevention or Reversal of Sensorial Hearing Loss Through Biological Mechanisms," filed January 23, 2001.
DATES:
Anyone wishing to object to the granting of this license has (15) days from the date of this notice to file written objections along with supporting evidence, if any.
ADDRESSES:
Written objections are to be filed with the Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave, Silver Spring, MD 20910-7500.
FOR FURTHER INFORMATION CONTACT:
Dr. Charles Schlagel, Director, Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave, Silver Spring, MD 20910-7500, telephone (301) 319-7428, fax (301) 319-7432, or E-Mail: schlagelc@nmrc.navy.mil.
Dated: March 14, 2003.
R. E. Vincent II,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, Federal Register Liaison Officer.
[FR Doc. 03-7351 Filed 3-26-03; 8:45 am]
BILLING CODE 3810-FF-M